https://tarsadia.com/cue-health-googles-provider-of-covid-19-tests-just-held-its-ipo/ 2022-02-11T17:20:42+00:00 https://tarsadia.com/wp-content/uploads/2021/09/106947190-1632510203445-mo_0924217_highres.jpg https://tarsadia.com/wp-content/uploads/2022/02/106947250-1632514113797-cue_health.jpg https://tarsadia.com/when-care-becomes-code/ 2022-02-11T17:34:31+00:00 https://tarsadia.com/wp-content/uploads/2022/02/care.jpg https://tarsadia.com/wp-content/uploads/2022/02/When-Care-Becomes-Codes.png https://tarsadia.com/yieldstreet-raises-100m-as-it-mulls-going-public-via-spac-eyes-acquisitions/ 2022-02-11T17:59:27+00:00 https://tarsadia.com/wp-content/uploads/2022/02/GettyImages-1270998711.jpg https://tarsadia.com/wp-content/uploads/2022/02/iPhone-12-_-12-Pro-e1654550464983.jpg https://tarsadia.com/b2b-venture-capital-funding-payments-innovation-investment-startup-faster-security-alternative-lending-sme-finance-supplier-accounts-payable/ 2022-02-11T18:14:19+00:00 https://tarsadia.com/wp-content/uploads/2022/02/b2b-venture-capital-funding-payments-innovation-investment-startup-faster-security-alternative-lending-sme-finance-supplier-accounts-payable-1000x600-1.jpg https://tarsadia.com/avantstay-a-platform-for-kitting-out-and-then-renting-out-high-end-vacation-rental-homes-raises-160m/ 2022-02-11T18:29:38+00:00 https://tarsadia.com/wp-content/uploads/2022/02/Buena-Vista-Coachella-Valley-CA-1.jpg https://tarsadia.com/specialty-prescription-management-provider-phil-secures-25mm-in-series-b-funding/ 2022-03-25T19:28:22+00:00 https://tarsadia.com/wp-content/uploads/2019/05/1920_refill-prescription-medications-covid-19-gettyimages.jpeg https://tarsadia.com/chronus-health-closes-22m-series-financing-round/ 2022-03-29T13:07:04+00:00 https://tarsadia.com/wp-content/uploads/2022/01/chronus.jpeg https://tarsadia.com/cue-health-confirms-covid-19-tests-can-detect-omicron-variant/ 2022-03-29T13:07:28+00:00 https://tarsadia.com/wp-content/uploads/2021/11/product-image-cue-covid-19-test.jpeg https://tarsadia.com/yieldstreet-raises-strategic-50m-follow-on-led-by-mayfair-equity-partners/ 2022-03-29T13:07:39+00:00 https://tarsadia.com/wp-content/uploads/2021/11/Digital-Investing-960x540-1.jpeg https://tarsadia.com/how-asias-latest-insurtech-unicorn-is-transforming-the-insurance-industry-by-improving-customer-experience/ 2022-03-29T13:08:19+00:00 https://tarsadia.com/wp-content/uploads/2021/11/Bolttech-Enters-Austria-Taking-Its-Footprint-to-12-Markets-Across-3-Continents.jpeg https://tarsadia.com/bolttech-extends-series-a-funding-round-to-us210-million/ 2022-03-29T13:08:29+00:00 https://tarsadia.com/wp-content/uploads/2021/09/1625200218_bolttech-Team-Shot.jpeg https://tarsadia.com/lereta-announces-sale-to-flexpoint-ford-and-vestar-capital-partners/ 2022-03-29T13:08:42+00:00 https://tarsadia.com/wp-content/uploads/2021/07/businessman-examining-report.jpeg https://tarsadia.com/cambridge-mobile-telematics-acquires-truemotion/ 2022-03-29T13:08:52+00:00 https://tarsadia.com/wp-content/uploads/2021/06/ScreenShot2020-10-24at6.32.55PM.png https://tarsadia.com/phil-announces-up-to-100m-strategic-growth-investment-from-warburg-pincus-fred-hassan-to-join-board-of-directors/ 2022-03-29T13:09:02+00:00 https://tarsadia.com/wp-content/uploads/2021/06/Phil-Inc..jpg https://tarsadia.com/cue-health-announces-completion-of-235-million-private-financing-to/ 2022-03-29T13:09:12+00:00 https://tarsadia.com/wp-content/uploads/2021/05/hero-4-homepage-l@3x-scaled.jpeg https://tarsadia.com/petal-launches-prism-data-to-offer-its-credit-technology-to-other-firms/ 2022-03-29T13:09:26+00:00 https://tarsadia.com/wp-content/uploads/2022/02/Petal-Prism-Data-credit-FinTech-1000x600-1.jpg https://tarsadia.com/lereta-acquires-flood-determinations-business/ 2022-03-29T13:09:38+00:00 https://tarsadia.com/wp-content/uploads/2020/12/breno-assis-r3WAWU5Fi5Q-unsplash-scaled.jpeg https://tarsadia.com/fleetcor-acquire-nvoicepay-leader-full-ap-automation/ 2022-03-29T13:09:47+00:00 https://tarsadia.com/wp-content/uploads/2019/03/fleetcor-nvoicepay-AP-automation.jpeg https://tarsadia.com/lereta-acquires-accumatch/ 2022-03-29T13:09:48+00:00 https://tarsadia.com/wp-content/uploads/2020/10/news-ai-art-accumatch.jpeg https://tarsadia.com/petal-nears-unicorn-status-with-fresh-140m-in-capital-to-upend-broken-traditional-credit-system/ 2022-06-07T06:38:58+00:00 https://tarsadia.com/wp-content/uploads/2022/01/1200x-1.jpeg https://tarsadia.com/wp-content/uploads/2022/02/Copy-of-1200x1200_0006_Layer-Comp-7.jpg https://tarsadia.com/digital-asset-technology-the-next-evolution-of-fintech-part-i/ 2023-04-28T15:41:04+00:00 https://tarsadia.com/wp-content/uploads/2023/04/Rikhil-Slide1-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/04/Rikhil-Slide0-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/04/Rikhil-Slide1-scaled.jpg https://tarsadia.com/part-ii-digital-asset-technology-compliance-and-security-tools/ 2023-05-12T15:31:49+00:00 https://tarsadia.com/wp-content/uploads/2023/05/CS-MM-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/05/Rikhil3.2-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/05/CS-MM-scaled.jpg https://tarsadia.com/healthcare-data-the-disruption-opportunity-why-this-time-is-different-by-dr-shubhra-jain-and-jay-santoro/ 2023-05-12T18:15:40+00:00 https://tarsadia.com/wp-content/uploads/2023/05/HC-Article-Thumbnail-3-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/04/1-Epic-Screenshot-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/04/2-Timeline-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/04/3-Market-Map-scaled.jpg https://tarsadia.com/part-iii-digital-asset-technology-institutional-trading-tools/ 2023-05-15T18:01:40+00:00 https://tarsadia.com/wp-content/uploads/2023/05/2023-05-03-Image-for-External-Content-Post-Part-III-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/05/PartIII-Graph2-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/05/2023-05-03-Image-for-External-Content-Post-Part-III-scaled.jpg https://tarsadia.com/amneal-launches-third-biosimilar-with-flynetra/ 2023-05-31T22:13:31+00:00 https://tarsadia.com/wp-content/uploads/2022/02/Amneal-2.jpg https://tarsadia.com/erasca-to-present-promising-preliminary-herkules-3-phase-1b-data-at-the-2023-asco-annual-meeting/ 2023-06-05T15:31:21+00:00 https://tarsadia.com/wp-content/uploads/2022/08/hero-home.jpg https://tarsadia.com/prolong-pharmaceuticals-announces-presentation-of-phase-1-data-from-hemera-1-clinical-study-of-pp-007-in-patients-with-acute-ischemic-stroke-at-the-late-breaking-science-session-isc-2023/ 2023-06-05T16:30:24+00:00 https://tarsadia.com/wp-content/uploads/2022/01/prolong-pharma-3.jpg https://tarsadia.com/catalys-pacific-launches-kirilys-therapeutics-as-a-multi-asset-precision-oncology-company/ 2023-06-05T16:38:03+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kirilys.jpg https://tarsadia.com/kashiv-biosciences-achieves-second-u-s-biosimilar-approval-with-fylnetra-pegfilgrastim-pbbk/ 2023-06-06T22:08:57+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kashiv-about-lab-test-1.png https://tarsadia.com/kashiv-biosciences-receives-approval-for-its-first-biosimilar-releukotm-filgrastim-ayow/ 2023-06-06T22:09:41+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kashiv-about-lab-test-1.png https://tarsadia.com/amneal-receives-505b2-nda-approval-from-fda-for-pemrydi-rtu-a-ready-to-use-oncology-injectable/ 2023-06-15T16:28:39+00:00 https://tarsadia.com/wp-content/uploads/2022/02/Amneal-2.jpg https://tarsadia.com/kashiv-biosciences-announces-successful-phase-1-study-results-of-adl018-a-biosimilar-candidate-to-xolair-omalizumab/ 2023-07-05T17:55:06+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kashiv-about-lab-test-1.png https://tarsadia.com/erasca-reports-first-quarter-2023-financial-results-and-business-updates/ 2023-07-06T21:50:58+00:00 https://tarsadia.com/wp-content/uploads/2022/08/hero-home.jpg https://tarsadia.com/amneal-reports-first-quarter-2023-financial-results/ 2023-07-18T08:54:27+00:00 https://tarsadia.com/wp-content/uploads/2022/02/Amneal-2.jpg https://tarsadia.com/tarsadia-strengthens-venture-growth-private-investing-practice-with-new-sector-heads/ 2023-10-04T15:03:51+00:00 https://tarsadia.com/wp-content/uploads/2022/03/G5A9779-21-05-04-1.jpg https://tarsadia.com/tarsadia-leads-the-charge-as-thought-leader-in-revolutionizing-payments/ 2023-10-04T17:58:24+00:00 https://tarsadia.com/wp-content/uploads/2022/03/G5A9779-21-05-04-1.jpg https://tarsadia.com/kashiv-biosciences-enters-into-exclusive-licensing-agreement-with-alvotech-for-development-commercialization-of-a-proposed-biosimilar-to-xolair-omalizumab/ 2023-10-04T17:58:34+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kashiv-about-lab-test-1.png https://tarsadia.com/payment-operations-software-the-multi-hundred-billion-dollar-market-to-optimize-payments-2/ 2023-10-09T20:49:34+00:00 https://tarsadia.com/wp-content/uploads/2023/10/8.-Verticals-scaled.jpg https://tarsadia.com/wp-content/uploads/2023/10/1.-Intro-Challenges-1024x768.jpg https://tarsadia.com/wp-content/uploads/2023/10/2.-Intro-Value-Chain-1024x768.jpg https://tarsadia.com/wp-content/uploads/2023/10/3.-Intro-Distribution-1024x574.jpg https://tarsadia.com/wp-content/uploads/2023/10/4.-Intro-eComm-1024x715.jpg https://tarsadia.com/wp-content/uploads/2023/10/5.-Orchestration-1024x768.jpg https://tarsadia.com/wp-content/uploads/2023/10/6.-Security-Compliance-1024x768.jpg https://tarsadia.com/wp-content/uploads/2023/10/7.-Verticals-Overview-1024x768.jpg https://tarsadia.com/wp-content/uploads/2023/10/8.-Verticals-1024x768.jpg https://tarsadia.com/payments-software-dooms-incumbent-processors/ 2023-10-23T15:11:08+00:00 https://tarsadia.com/wp-content/uploads/2023/10/software-disrupts-processors-660x330-1.jpg https://tarsadia.com/wp-content/uploads/2023/10/Payment-operations-value-chain.jpg https://tarsadia.com/wp-content/uploads/2023/10/tectonic-shift-300x170@2x.jpg https://tarsadia.com/wp-content/uploads/2023/10/Rikhil-Bajaj-Tarsadia.jpg https://tarsadia.com/payment-operations-software-and-the-transformation-of-the-payments-landscape/ 2023-11-30T22:51:33+00:00 https://tarsadia.com/wp-content/uploads/2023/11/PaymentsPodcast.png https://tarsadia.com/kashiv-biosciences-announces-completion-of-enrollment-for-phase-iii-clinical-trial-of-adl018-a-biosimilar-candidate-to-xolair-omalizumab/ 2024-07-26T22:31:41+00:00 https://tarsadia.com/wp-content/uploads/2023/06/kashiv-about-lab-test-1.png https://tarsadia.com/u-s-food-and-drug-administration-fda-grants-prolong-pharmaceuticals-fda-fast-track-designation-for-novel-stroke-therapy-pp-007-in-hemera-1-clinical-study/ 2024-11-01T16:26:42+00:00 https://tarsadia.com/wp-content/uploads/2022/01/prolong-pharma-3.jpg https://tarsadia.com/kashiv-biosciences-appoints-dr-sandeep-nilkanth-athalye-as-global-ceo/ 2024-11-01T17:03:07+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-expands-leadership-team-with-new-chief-financial-officer-and-chief-legal-officer/ 2024-12-10T15:57:05+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-announces-successful-phase-1-results-for-abatacept-biosimilar-candidate-kshb002/ 2025-01-28T22:57:01+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/prolong-pharmaceuticals-to-present-preliminary-phase-1-data-from-hemera-1-for-pp-007-in-acute-ischemic-stroke-ais-at-the-2025-international-stroke-conference-isc/ 2025-02-06T19:19:42+00:00 https://tarsadia.com/wp-content/uploads/2022/01/prolong-pharma-3.jpg https://tarsadia.com/kashiv-biosciences-secures-150-million-debt-financing-from-goldentree-asset-management/ 2025-04-07T16:47:37+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/uk-medicines-and-healthcare-products-regulatory-agency-has-validated-and-accepted-the-marketing-authorization-application-for-adl-018-a-proposed-biosimilar-of-xolair-omalizumab/ 2025-04-09T19:09:18+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-announces-positive-topline-results-from-confirmatory-efficacy-study-of-adl-018-biosimilar-candidate-to-xolair-omalizumab/ 2025-06-26T14:26:29+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-and-ms-pharma-enter-into-mena-license-and-supply-agreement-for-adl-018-biosimilar-candidate-to-xolair-bomalizumab/ 2025-08-05T17:19:57+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-and-cristalia-enter-into-licensing-and-supply-agreement-for-omalizumab-biosimilar-adl-018-in-latin-america/ 2025-09-11T15:12:20+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-and-jamp-pharma-corporation-announce-the-launch-of-pexegra-and-filra-biosimilars-in-canada/ 2025-09-24T14:58:20+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/kashiv-biosciences-announces-submission-of-biologics-license-application-to-u-s-fda-and-acceptance-of-market-authorization-application-by-european-medicines-agency-for-adl-018-a-proposed-biosimilar/ 2025-10-06T16:02:10+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png https://tarsadia.com/prolong-pharmaceuticals-to-present-phase-1-2-data-from-hemera-1-for-pp-007-in-acute-ischemic-stroke-ais-at-the-2025-world-stroke-conference-wsc/ 2025-10-23T16:45:52+00:00 https://tarsadia.com/wp-content/uploads/2022/01/prolong-pharma-3.jpg https://tarsadia.com/amneal-completes-acquisition-of-kashiv-biosciences-creating-a-global-biosimilar-leader/ 2026-08-12T17:43:11+00:00 https://tarsadia.com/wp-content/uploads/2022/02/KB-Photo-2.png